MELFIAT Drug Patent Profile
Which patents cover Melfiat, and what generic alternatives are available?
Melfiat is a drug marketed by Numark and is included in two NDAs.
The generic ingredient in MELFIAT is phendimetrazine tartrate. There is one drug master file entry for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Melfiat
A generic version of MELFIAT was approved as phendimetrazine tartrate by CHARTWELL on October 30th, 1991.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MELFIAT?
- What are the global sales for MELFIAT?
- What is Average Wholesale Price for MELFIAT?
Summary for MELFIAT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 11 |
| Patent Applications: | 547 |
| DailyMed Link: | MELFIAT at DailyMed |
US Patents and Regulatory Information for MELFIAT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Numark | MELFIAT | phendimetrazine tartrate | TABLET;ORAL | 083790-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Numark | MELFIAT-105 | phendimetrazine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 087487-001 | Oct 13, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
